Halliburton Company vs UnitedHealth Group Inc — how do they compare? Halliburton Company trades at $32.44 (market cap $26.45B), while UnitedHealth Group Inc trades at $370.77 (market cap $337.48B). The key difference: UnitedHealth Group Inc is far larger — about 12.8× Halliburton Company's market cap, and UnitedHealth Group Inc pays the higher dividend (2.47%). Which is the better fit depends on your goals — on Pluang, investors hold Halliburton Company for 89 Days and UnitedHealth Group Inc for 97 Days on average.
| HAL | UNH | |
|---|---|---|
Market Cap | $26.45B | $337.48B |
Volume | 11,229,274 | 5,620,541 |
Sector | Energy | Health |
52-Week High | $42.98 | $436.35 |
52-Week Low | $21.82 | $259.02 |
Typical Hold Time | 89 Days | 97 Days |
Enterprise Value | $32.60B | $379.34B |
Dividend Yield | 2.14% | 2.47% |
Signals from Pluang's Aura AI — not financial advice
Halliburton (HAL) trades at $32.57, down 0.46% on the day, amid a bearish technical signal from moving averages. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 results pending. Recent news highlights expansion in Venezuela and a major contract win in Cyprus, signaling growth initiatives. Financials show solid profitability with a net income margin of 7.16% and a P/E ratio of 16.62, though 2025 revenue dipped slightly to $22.18 billion.
The outlook is supported by strong analyst consensus with a $43.11 price target and 73% buy ratings, but risks include oil price volatility and execution challenges in new markets. Cash flow trends have been mixed, with 2025 net cash flow negative $412 million, though 2026 projects a return to positive territory.
UnitedHealth Group (UNH) trades at $370.95, down 1.43% on the day, with a bullish technical signal and strong analyst support. Recent earnings beats and a raised 2026 outlook highlight fundamental strength, though net income margins have compressed. The stock is supported by a $2.32 dividend payment scheduled for September 22, 2026, and positive sentiment around Medicare Advantage and Optum growth.
The outlook remains positive with an 82.7% analyst buy rating and a $473.89 consensus price target, implying significant upside. Key risks include regulatory pressures and medical cost trends, but strategic AI investments and solid cash flow support long-term growth. Investors should weigh the attractive valuation against execution risks in a dynamic healthcare landscape.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Halliburton is one of the three largest oilfield service firms in the world, offering superior expertise in a number of business lines, including completion fluids, wireline services, cementing, and countless others. It's the number one pressure pumper in North America, and has been a leading innovator in hydraulic fracturing over the last two decades.
Read more on HAL →UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →